Drug Type Biosimilar, Monoclonal antibody |
Synonyms CMAB-022, CMAB022 |
Target |
Mechanism IL-12 inhibitors(Interleukin-12 inhibitors), IL-23 inhibitors(Interleukin-23 inhibitors) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
AS | Preclinical | CN | - | |
Arthritis, Psoriatic | Preclinical | CN | - | |
Non-radiographic axial spondyloarthritis | Preclinical | CN | - | |
Plaque psoriasis | Preclinical | CN | - |